Diabetes and travel insurance costs: let's talk about remission

Angelopoulou, K., Leslie, W., McCombie, L., Lean, M. and Hankey, C. (2019) Diabetes and travel insurance costs: let's talk about remission. Practical Diabetes, 36(1), pp. 20-21. (doi: 10.1002/pdi.2205)

Full text not currently available from Enlighten.


The growing global prevalence of type 2 diabetes mellitus places enormous burden on health services and affected individuals. As with other medical diagnoses, the presence of type 2 diabetes will impact on premiums for things such as travel insurance. Interventions which result in remission of what was previously viewed as a chronic progressive disease are attracting interest from health service providers and people with the disease. We investigated the influence of type 2 diabetes status on travel insurance through obtaining quotes for a set number of scenarios from a variety of providers. It was found that at this point there is inconsistency across travel insurance providers in terms of the impact of diabetes status on premiums paid with no specific recommendations for people who meet the criteria for remission coding. People with type 2 diabetes, including those who have achieved remission, should be advised to seek quotes from various providers in order to get the most advantageous cover for premiums paid.

Item Type:Articles
Glasgow Author(s) Enlighten ID:McCombie, Ms Louise and Lean, Professor Michael and Hankey, Dr Catherine and Leslie, Dr Wilma
Authors: Angelopoulou, K., Leslie, W., McCombie, L., Lean, M., and Hankey, C.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Practical Diabetes
ISSN (Online):2047-2900
Published Online:13 February 2019

University Staff: Request a correction | Enlighten Editors: Update this record